89bio Inc (ETNB) Insider Trading
- $169,656,801.27
- $11,245,786.55
- Dec. 6, 2024
- Ram Waisbourd
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 6, 2024 | CEO | 5,000 | $7.89 | Buy | $39,450.00 | |
Dec. 5, 2024 | Director | 10,000 | $8.00 | Buy | $80,000.00 | |
Nov. 22, 2024 | CEO | 10,000 | $8.35 | Buy | $83,500.00 | |
March 4, 2024 | Director | 1,350,000 | $15.35 | Buy | $20,722,500.00 | |
Feb. 26, 2024 | CEO | 4,477 | $10.76 | Sell | $48,172.52 | |
July 17, 2023 | Director | 12,500 | $18.80 | Sell | $235,000.00 | |
June 5, 2023 | CEO | 15,000 | $20.00 | Sell | $300,000.00 | |
June 1, 2023 | Director | 6,250 | $17.91 | Sell | $111,937.50 | |
May 9, 2023 | Insider | 13,683 | $18.11 | Sell | $247,799.13 | |
April 4, 2023 | CFO | 8,721 | $14.95 | Sell | $130,378.95 | |
March 30, 2023 | Director | 6,250 | $3.62 | Buy | $22,625.00 | |
March 28, 2023 | Director | 61,538 | $16.15 | Buy | $993,838.70 | |
March 24, 2023 | Director | 2,461,538 | $16.25 | Buy | $39,999,992.50 | |
March 23, 2023 | CEO | 15,000 | $16.00 | Sell | $240,000.00 | |
March 23, 2023 | CFO | 5,000 | $16.11 | Sell | $80,550.00 | |
Feb. 21, 2023 | CFO | 2,540 | $13.89 | Sell | $35,280.60 | |
Feb. 8, 2023 | CFO | 1,480 | $14.41 | Sell | $21,326.80 | |
Feb. 3, 2023 | CFO | 3,592 | $13.04 | Sell | $46,839.68 | |
Jan. 3, 2023 | CFO | 5,947 | $12.51 | Sell | $74,396.97 | |
Oct. 18, 2022 | Director | 1,172,741 | $7.65 | Buy | $8,971,468.65 | |
July 1, 2022 | Director | 2,816,900 | $3.55 | Buy | $9,999,995.00 | |
Feb. 1, 2022 | Insider | 7,000 | $5.70 | Sell | $39,900.00 | |
Jan. 27, 2022 | CEO | 5,000 | $7.50 | Buy | $37,500.00 | |
Jan. 25, 2022 | Major Shareholder | 49,091 | $8.40 | Sell | $412,364.40 | |
Dec. 16, 2021 | Insider | 7,000 | $11.48 | Sell | $80,360.00 | |
Nov. 16, 2021 | Insider | 7,000 | $16.49 | Sell | $115,430.00 | |
Oct. 18, 2021 | Insider | 7,000 | $17.49 | Sell | $122,430.00 | |
Sept. 16, 2021 | Insider | 7,000 | $19.46 | Sell | $136,220.00 | |
July 16, 2021 | Insider | 7,000 | $16.80 | Sell | $117,600.00 | |
June 2, 2021 | Director | 22,138 | $18.77 | Buy | $415,530.26 | |
May 28, 2021 | Director | 123,505 | $18.77 | Buy | $2,318,188.85 | |
May 26, 2021 | Director | 48,377 | $18.03 | Buy | $872,237.31 | |
April 21, 2021 | Director | 850 | $27.60 | Sell | $23,460.00 | |
April 19, 2021 | CFO | 10,000 | $25.00 | Sell | $250,000.00 | |
April 16, 2021 | Insider | 7,000 | $24.22 | Sell | $169,540.00 | |
March 16, 2021 | Insider | 7,000 | $24.20 | Sell | $169,400.00 | |
Jan. 19, 2021 | Insider | 7,000 | $21.16 | Sell | $148,120.00 | |
Dec. 16, 2020 | Insider | 7,000 | $27.04 | Sell | $189,280.00 | |
Sept. 21, 2020 | Director | 275,000 | $28.00 | Sell | $7,700,000.00 | |
Sept. 17, 2020 | Director | 1,300,000 | $28.00 | Buy | $36,400,000.00 | |
July 10, 2020 | Major Shareholder | 109,090 | $27.50 | Buy | $2,999,975.00 | |
July 8, 2020 | Director | 275,000 | $27.50 | Buy | $7,562,500.00 | |
Nov. 11, 2019 | Major Shareholder | 575,000 | $27.00 | Buy | $15,525,000.00 | |
Nov. 11, 2019 | Director | 837,500 | $27.00 | Buy | $22,612,500.00 |
Insiders are both buying and selling 89bio Inc stock.
The insider traders at 89bio Inc are: Ram Waisbourd, Ra Capital Management, L.P., Ryan Martins, Rohan Palekar, Orbimed Advisors Llc, Longitude Capital Partners Iii, Michael R Hayden, Quoc Le-Nguyen, Edward Morrow Atkinson III, Kathleen Laporte, Gregory Grunberg, and Charles Mcwherter
The most active insider trader at 89bio Inc is Ram Waisbourd with 10 trades.
Orbimed Advisors Llc has sold the most 89bio Inc stock with a total value of $8,524,728.80.
Ra Capital Management, L.P. has bought the most 89bio Inc stock with a total value of $147,984,912.57.
The most recent insider trade for 89bio Inc was on Dec. 6, 2024.
The single biggest insider buy for 89bio Inc was from Ra Capital Management, L.P. with a total value of $39,999,992.50 on March 24, 2023.
The single biggest insider sell for 89bio Inc was from Orbimed Advisors Llc with a total value of $7,700,000.00 on Sept. 21, 2020.